Sign In
Buy GH
$127.03
-3.14 (-2.41%)
At Close: Jun 03, 2026
Guardant Health to Participate in Upcoming Investor Conferences
04:05pm, Tuesday, 07'th May 2024
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the following investor conferences. BofA S
Guardant (GH) Gears Up for Q1 Earnings: Here's What to Expect
12:31pm, Tuesday, 07'th May 2024
Investors' focus will likely be on revenues generated by Guardant Health (GH) from its precision oncology testing business.
Curious about Guardant Health (GH) Q1 Performance? Explore Wall Street Estimates for Key Metrics
10:22am, Monday, 06'th May 2024
Besides Wall Street's top -and-bottom-line estimates for Guardant Health (GH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Monday, 22'nd Apr 2024
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
FDA Advisory Panel Review of Guardant Health's Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23
08:52am, Monday, 22'nd Apr 2024
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical Genetics Panel of the U.S. Food and Drug Admini
Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024
04:05pm, Thursday, 18'th Apr 2024
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the first quarter 2024 after market c
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting
08:05am, Wednesday, 03'rd Apr 2024
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will present data from nine studies highlighting advances in methylatio
The next Nvidia? 3 stocks poised for massive growth in 2024
05:17am, Wednesday, 03'rd Apr 2024
Starting in 2014, and even more notably in 2016 as Warren Buffett himself chipped in, Apple (NASDAQ: AAPL) became the benchmark company, and investors around the world were trying to find the ‘next
Better Than ChatGPT? New Super AI Bot Says Buy These 3 Stocks.
08:35am, Monday, 01'st Apr 2024
It's been nearly one and a half years since ChatGPT went live, but it sure doesn't feel like it. ChatGPT has shaken up many sectors, and triggered an AI revolution.
Guardant Health: Shield Launch Could Drive Multiple Expansion
01:31pm, Friday, 22'nd Mar 2024
GH can prove to the market they have a competitive product in Shield that can gain a foothold in the roughly 50m unscreened CRC patient population. Shield's strongest adherence rate, with the potentia
PALO ALTO, Calif.--(BUSINESS WIRE)--ECLIPSE study to be published in NEJM shows Shield blood-based screening test detects 83% of people with colorectal cancer.
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Wednesday, 06'th Mar 2024
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on February 15, 2024, the Compensation Committee of Guardant's Board
Top 3 Wall Street stock picks for March
08:51am, Wednesday, 06'th Mar 2024
While the stock market is not yet free of recessionary fears and remains affected by high interest rates, 2024 has, so far, brought significant positive developments if things are to be judged by majo
New Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap
05:30am, Friday, 01'st Mar 2024
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the results of a new survey showing patients and physicians overwhelmingly
Guardant Health, Inc. (GH) Q4 2023 Earnings Call Transcript
11:43pm, Thursday, 22'nd Feb 2024
Guardant Health, Inc. (GH) Q4 2023 Earnings Call Transcript
